Kremezin (AST-120) delays the progression of diabetic nephropathy in Japanese type 2 diabetic patients
Diabetes Care
.
2005 Oct;28(10):2590.
doi: 10.2337/diacare.28.10.2590.
Authors
Hiroyuki Shimizu
,
Shuichi Okada
,
Oh-I Shinsuke
,
Masatomo Mori
PMID:
16186309
DOI:
10.2337/diacare.28.10.2590
No abstract available
Publication types
Clinical Trial
Letter
MeSH terms
Carbon / administration & dosage*
Diabetes Mellitus, Type 2 / complications*
Diabetic Nephropathies / drug therapy*
Humans
Japan
Oxides / administration & dosage*
Treatment Outcome
Substances
Oxides
Carbon
AST 120